Omentin-1 Is Decreased in Maternal Plasma, Placenta and Adipose Tissue of Women with Pre-Existing Obesity
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this study was to determine (i) the effect of maternal obesity and gestational diabetes mellitus (GDM) on (i) the circulating levels of omentin-1 in cord and maternal plasma, and (ii) gene expression and release of omentin-1 from human placenta and adipose tissue. The effect of pregnancy on circulating omentin-1 levels was also determined. DESIGN: Omentin-1 levels were measured in maternal and cord plasma from obese and non-obese normal glucose tolerant women (NGT; n = 44) and women with GDM (n = 39) at the time of term elective Caesarean section. Placenta and adipose tissue expression and release of omentin-1 was measured from 22 NGT and 22 GDM women collected at the time of term elective Caesarean section. Omentin-1 levels were also measured in maternal plasma from 13 NGT women at 11 and 28 weeks gestation and 7 weeks postpartum. RESULTS: Maternal obesity was associated with significantly lower omentin-1 levels in maternal plasma; however, there was no effect of maternal obesity on cord omentin levels. Omentin-1 gene expression was lower in placenta and adipose tissue obtained from women with pre-existing obesity. In addition to this, adipose tissue release of omentin-1 was significantly lower from obese pregnant women. Omentin-1 levels were significantly lower in non-obese GDM compared to non-obese NGT women. However, there was no difference in omentin-1 levels between obese NGT and obese GDM women. There was no effect of GDM on cord omentin levels, and placental and adipose tissue omentin-1 expression. Maternal omentin-1 levels were negatively correlated with fetal birthweight and fetal ponderal index. CONCLUSIONS: The data presented in this study demonstrate that pre-existing maternal obesity is associated with lower omentin-1 expression in placenta, adipose tissue and maternal plasma. Alteration in omentin-1 in pregnancy may influence the development of metabolic disorders in offspring later in life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Yang, R.-Z., Lee, M.-J., Hu, H., Pray, J., Wu, H.-B., Hansen, B. C., Shuldiner, A. R., Fried, S. K., McLenithan, J. C., & Gong, D.-W. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00572.2004 · Cited by 884
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Barbour, L. A., McCurdy, C. E., Hernandez, T. L., Kirwan, J. P., Catalano, P. M., & Friedman, J. E. (2007) · Diabetes Care · doi:10.2337/dc07-s202 · Cited by 811
Tan, B. K., Adya, R., Farhatullah, S., Lewandowski, K. C., O’Hare, P., Lehnert, H., & Randeva, H. S. (2008) · Diabetes · doi:10.2337/db07-0990 · Cited by 273 · cited 4×
“parallel with the increase of visceral obesity [11,16,17].”
BackgroundInfluentialAssociation between Obesity during Pregnancy and Increased Use of Health Care
Chu, S. Y., Bachman, D. J., Callaghan, W. M., Whitlock, E. P., Dietz, P. M., Berg, C. J., O'Keeffe-Rosetti, M., Bruce, F. C., & Hornbrook, M. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706786 · Cited by 242 · cited 2×
“In addition to this, they are also associated with substantial societal medical costs [5].”
BackgroundObesity, pregnancy, inflammation, and vascular function
Denison, F. C., Roberts, K. A., Barr, S. M., & Norman, J. E. (2010) · Reproduction · doi:10.1530/rep-10-0074 · Cited by 221 · cited 1×
“Whether omentin-1 is related to vascular dysfunction in this cohort of patients is not known; however, obese pregnant women have subclinical atherosclerosis, vascular dysfunction and low-grade inflammation [34,35].”
BackgroundScreening for biomarkers predictive of gestational diabetes mellitus
Georgiou, H. M., Lappas, M., Georgiou, G. M., Marita, A., Bryant, V. J., Hiscock, R., Permezel, M., Khalil, Z., & Rice, G. E. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0037-8 · Cited by 151
Self-citation
Cited by
Abell, S., De Courten, B., Boyle, J., & Teede, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613442 · Cited by 239
“Maternal omentin was significantly lower in non-obese GDM women compared to non-obese NGT women, but no different between obese GDM and obese NGT women [114].”
BackgroundResultAdipokines in gestational diabetes
Fasshauer, M., Blüher, M., & Stumvoll, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70176-1 · Cited by 230
Adipose Tissue-Derived Omentin-1 Function and Regulation
Watanabe, T., Watanabe‐Kominato, K., Takahashi, Y., Kojima, M., & Watanabe, R. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160043 · Cited by 210
Lappas, M. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.001 · Cited by 97
“[37] Barker G, Lim R, Georgiou HM, et al.”
BackgroundSelf-citationNew Insights into Adipokines in Gestational Diabetes Mellitus
Valencia-Ortega, J., González-Reynoso, R., Ramos-Martínez, E. G., Ferreira-Hermosillo, A., Peña-Cano, M. I., Morales-Ávila, E., & Saucedo, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116279 · Cited by 39
“(2012) [83] 22 GDM and 22 controls VAT for mRNA and protein levels ↔ In controls, a negative effect of obesity on mRNA and protein levels of omentin-1 was observed.”
Background
Metadata
- Authors
- Barker, G., Lim, R., Georgiou, H. M., & Lappas, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-28
- Volume
- 7
- Issue
- 8
- Pages
- e42943
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2094977668
- Cited by
- 69
- References
- 8
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.